Avalon Pharmaceutical
Latest round
- Series B
Last raised
- Dec 2001
Total raised
- $80M
Investors
- 14
About Avalon Pharmaceutical
Avalon Pharmaceutical, Inc.Founded in 1999 in Germantown, US, Avalon Pharmaceutical, Inc. specializes in healthcare solutions, particularly innovative therapeutic treatments. The company completed its IPO on September 29, 2005, and has engaged in 8 total deals since its inception.AvalonRx specializes in developing innovative healthcare solutions, focusing on advanced therapeutic treatments and healthcare technology platforms. The company's offerings include proprietary therapies for specific medical conditions and digital health tools that enhance patient engagement and streamline clinical workflows.In 2008, AvalonRx reported revenue of USD 311,000 with an EBITDA of USD -20,491,000.Avalon Pharmaceutical, Inc. aims to launch new products and expand into additional markets. The company is targeting new geographic regions for growth, particularly in North America and Europe, following its IPO in September 2005.
Who invested in Avalon Pharmaceutical
14 investors across 2 rounds
See all investors in Avalon Pharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Avalon Pharmaceutical
Who invested in Avalon Pharmaceutical?
Avalon Pharmaceutical has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avalon Pharmaceutical raised?
Avalon Pharmaceutical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Avalon Pharmaceutical last raise money?
Avalon Pharmaceutical's most recent round on record is a Series B, in Dec 2001.
What does Avalon Pharmaceutical do?
Avalon Pharmaceutical is a biotechnology company.
Where is Avalon Pharmaceutical headquartered?
Avalon Pharmaceutical is headquartered in Germantown, US.
Which VCs invest in companies like Avalon Pharmaceutical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Avalon Pharmaceutical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Avalon Pharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.